GV20 Therapeutics
Registry sponsor category
Industry
- Other names
- GV20 Therapeutics
- Company name
- GV20 Therapeutics
- Organisation type
- Industry
- Registry sponsor category
- Industry
- Publicly traded (proxy)
- No
- Listing at source
- Listed
Related records
Trials (4)
- A Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors.
- A Study of GV20-0251 in Advanced or Refractory Solid Tumors
- A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
- Study of GV20-0251 in Participants With Solid Tumor Malignancies